Our News on Newswise

Newswise: Victoria-Blaho-Profile.jpeg

Victoria Blaho receives prestigious Lina M. Obeid Award

Victoria Blaho, Ph.D., assistant professor in the Immunity and Pathogenesis Program at Sanford Burnham Prebys, has received the first-ever Lina M. Obeid Award for her promising research on the biology of sphingolipids. The award honors Obeid, a...
22-Apr-2021 3:00 PM EDT Add to Favorites

Newswise: imageforPRChandaMolecularCell.jpg

COVID-19: Scientists identify human genes that fight infection

Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers’ understanding of factors...
16-Apr-2021 1:10 PM EDT Add to Favorites

Newswise: ani-deshpande-bo-rui-chen-anagha-deshpande_in.jpeg

Scientists identify potential drug candidates for deadly pediatric leukemia

Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that two existing drug candidates—JAK inhibitors and Mepron—hold potential as treatments for a deadly acute myeloid leukemia (AML) subtype that is more common in...
14-Apr-2021 12:25 PM EDT Add to Favorites

Newswise: Zeev_Ronai_profile.jpg

Starving tumors by blocking glutamine uptake

Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a drug candidate that blocks the uptake of glutamine, a key food source for many tumors, and slows the growth of melanoma.
17-Mar-2021 5:55 PM EDT Add to Favorites

Newswise: CosimoCommisso.jpg

Scientists shrink pancreatic tumors by starving their cellular “neighbors”

Scientists at Sanford Burnham Prebys Medical Discovery Institute demonstrated for the first time that blocking “cell drinking,” or macropinocytosis, in the thick tissue surrounding a pancreatic tumor slowed tumor growth—providing more evidence...
16-Mar-2021 3:05 PM EDT Add to Favorites

Newswise: sumit_chanda.jpeg

Leprosy drug holds promise as at-home treatment for COVID-19

A Nature study shows that the leprosy drug clofazimine, which is FDA approved and on the World Health Organization’s List of Essential Medicines, exhibits potent antiviral activities against SARS-CoV-2 and prevents the exaggerated inflammatory...
16-Mar-2021 6:00 AM EDT Add to Favorites

Newswise: evan-snyder_n.jpg

Evan Snyder named Fellow of the American Institute for Medical and Biological Engineering

The American Institute for Medical and Biological Engineering (AIMBE) has elected to its College of Fellows Evan Y. Snyder, M.D., Ph.D., professor and founding director of the Center for Stem Cells and Regenerative Medicine at Sanford Burnham Prebys...
23-Feb-2021 8:00 AM EST Add to Favorites

Newswise: Zeev_Ronai_profile.jpg

Ze’ev Ronai named director of Sanford Burnham Prebys’ Cancer Center

Sanford Burnham Prebys Medical Discovery Institute has named renowned cancer researcher Ze’ev Ronai, Ph.D., director of its National Cancer Institute (NCI)-designated Cancer Center.
25-Jan-2021 8:00 AM EST Add to Favorites


See All News

Our YouTube Videos

About

Sanford Burnham Prebys is a preeminent, independent biomedical research institute dedicated to understanding human biology and disease and advancing scientific discoveries to profoundly impact human health. For over 40 years, our research has produced breakthroughs in cancer, neuroscience, immunology and children’s diseases, and is anchored by our NCI-designated cancer center and advanced drug discovery capabilities. For more information, visit us at SBPdiscovery.org or on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.

Contacts

Michaela Andrews
Communications Coordinator

mandrews@sbpdiscovery.org

(858) 795-5158

Susan Gammon
Director of Communications

sgammon@sbpdiscovery.org

(858) 795-5012

Monica May
Science Writer

mmay@sbpdiscovery.org

858-795-5147

Twitter

close
0.99617